Viridian Therapeutics, Inc.

VRDN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001590750

SEC filings (opens in a new tab)

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Viridian Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of VRDN: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	105	1	122	+18
Shares	38.0M	30.1K	41.2M	+3.30M (+8.7%)
Value	$778.5M	$617.6K	$1.21B	+$428.1M (+55.0%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Viridian Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to VRDN in Q4 2022
Institution	Shares	Value	% of portfolio
Alliancebernstein L.P.	923,833	$27.0M	0.01%
Octagon Capital Advisors LP	824,200	$24.1M	3.75%
Braidwell LP	313,403	$9.15M	0.31%
Ameriprise Financial Inc	267,765	$7.82M	0.00%
Moore Capital Management, LP	140,000	$4.09M	0.12%
Norges Bank	134,200	$3.92M	0.00%
Connor, Clark & Lunn Investment Management Ltd.	131,539	$3.84M	0.02%
Wellington Management Group LLP	120,503	$3.52M	0.00%
Algert Global LLC	65,253	$1.91M	0.11%
Kopp Family Office, LLC	64,388	$1.88M	1.13%
Moody Aldrich Partners LLC	58,911	$1.72M	0.35%
Trexquant Investment LP	35,887	$1.05M	0.03%
Brookfield Asset Management Inc.	27,915	$815.4K	0.00%
Mirabella Financial Services LLP	25,769	$752.7K	0.07%
Federated Hermes, Inc.	20,835	$608.6K	0.00%
UBS Asset Management Americas Inc	19,470	$568.7K	0.00%
SEI Investments Co	18,936	$553.1K	0.00%
Caxton Associates LP	17,974	$525.0K	0.04%
Squarepoint Ops LLC	17,207	$502.6K	0.00%
US Bancorp	11,222	$327.8K	0.00%
Kula Investments, LLC	10,580	$309.0K	0.11%
Principal Financial Group Inc	10,129	$295.9K	0.00%
Teacher Retirement System of Texas	8,862	$259.0K	0.00%
Arizona State Retirement System	8,443	$246.6K	0.00%
Glenmede Trust Co NA	8,265	$241.4K	0.00%
Engineers Gate Manager LP	8,136	$237.7K	0.01%
AQR Capital Management LLC	7,403	$216.2K	0.00%
Virtus ETF Advisers LLC	5,017	$146.5K	0.08%
Silverarc Capital Management, LLC	3,000	$87.6K	0.03%
Nisa Investment Advisors, LLC	25	$1.00K	0.00%

Sold out (12)

Institutions that held Viridian Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of VRDN in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Eversept Partners, LP	478,387	$9.81M
Renaissance Technologies LLC	101,600	$2.08M
UBS Oconnor LLC	81,870	$1.68M
BNP Paribas Arbitrage, SA	35,445	$727.0K
Parkman Healthcare Partners LLC	35,358	$725.0K
Walleye Trading LLC	27,118	$556.0K
Seven Grand Managers, LLC	25,000	$513.0K
Alps Advisors Inc	20,848	$428.0K
Soleus Capital Management, L.P.	19,518	$400.0K
Occudo Quantitative Strategies LP	15,764	$323.0K
Wells Fargo & Company	808	$16.0K
GPS Wealth Strategies Group, LLC	3	$0

Not filed for Q4 2022 yet (1)

Institutions that held Viridian Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VRDN in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Jefferies Group LLC	30,110	$617.6K